Compound Detail
CHEMBL5429772
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C[C@]12CC[C@H]3[C@]4(C=C[C@]5(C[C@@H](O)CC[C@]35C)OO4)[C@@H]1CC/C2=N\N=C1/C(=O)Nc2ccc(Cl)cc21
Basic Information
| ChEMBL ID | CHEMBL5429772 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WRUQYKGJEKUOJT-XWSRURFHSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
496.0
MW (Da)
4.82
ALogP
6
HBA
2
HBD
92.5
PSA (Ų)
0.33
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 5.25
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HeLa | IC50 | = | 5690.0 | nM | 5.25 | Cytotoxicity against human HeLa cells assessed as cell growth inhibition incubat... | 38107170 |
| HepG2 | IC50 | = | 7970.0 | nM | 5.1 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 38107170 |
| MCF7 | IC50 | = | 9050.0 | nM | 5.04 | Antiproliferative activity against human MCF7 cells assessed as inhibition of ce... | 38107170 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38107170 | 10.1039/d3md00560g | HepG2 | 1 |
| 38107170 | 10.1039/d3md00560g | MCF7 | 1 |
| 38107170 | 10.1039/d3md00560g | HeLa | 1 |
Data from ChEMBL 36 via Core Engine